Neonatal Hydrocortisone Treatment: Neurodevelopmental Outcome and MRI at School Age in Preterm-born Children

Journal of Pediatrics

Volumn 150, Issue 4, 2007, Pages 351-357

  Rademaker, Karin J ^a   Uiterwaal, Cuno S P M ^a   Groenendaal, Floris ^a   Venema, Monica M A T Uniken ^a   van Bel, Frank ^a   Beek, Frederik J ^a   van Haastert, Ingrid C ^a   Grobbee, Diederick E ^a   de Vries, Linda S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; BRAIN; BRAIN DAMAGE; BRAIN DEVELOPMENT; CEREBRAL PALSY; CHILD; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INTELLIGENCE QUOTIENT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NEWBORN PERIOD; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; SEX; SMALL FOR DATE INFANT; VERBAL MEMORY; VISUOMOTOR COORDINATION; WECHSLER INTELLIGENCE SCALE;

ANTI-INFLAMMATORY AGENTS; BRAIN DISEASES; BRONCHOPULMONARY DYSPLASIA; CHILD; CHILD DEVELOPMENT; COGNITION; FEMALE; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; INFANT, PREMATURE; MAGNETIC RESONANCE IMAGING; MALE; MOTOR SKILLS; NERVOUS SYSTEM; TIME;

EID: 33947191491     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.10.051     Document Type: Article

References (35)

1. Lemons J.A., Bauer C.R., Oh W., Korones S.B., Papile L.A., Stoll B.J., et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996: NICHD Neonatal Research Network. Pediatrics 107 (2001) E1
2. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev (2003) CD001146
3. Yeh T.F., Lin Y.J., Huang C.C., Chen Y.J., Lin C.H., Lin H.C., et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101 (1998) E7
4. O'Shea T.M., Kothadia J.M., Klinepeter K.L., Goldstein D.J., Jackson B.G., Weaver III R.G., et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 104 (1999) 15-21
5. Shinwell E.S., Karplus M., Reich D., Weintraub Z., Blazer S., Bader D., et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 83 (2000) F177-F181
6. Baud O. Postnatal steroid treatment and brain development. Arch Dis Child Fetal Neonatal Ed 89 (2004) F96-F100
7. Lodygensky G.A., Rademaker K., Zimine S., Gex-Fabry M., Lieftink A.F., Lazeyras F., et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 116 (2005) 1-7
8. Rademaker K.J., Rijpert M., Uiterwaal C.S., Lieftink A.F., van Bel F., Grobbee D.E., et al. Neonatal hydrocortisone treatment related to 1H-MRS of the hippocampus and short-term memory at school age in preterm born children. Pediatr Res 59 (2006) 309-313
9. Papile L.A., Burstein J., Burstein R., and Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 92 (1978) 529-534
10. de Vries L.S., Eken P., and Dubowitz L.M. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 49 (1992) 1-6
11. Rademaker K.J., Lam J.N., van Haastert I.C., Uiterwaal C.S., Lieftink A.F., Groenendaal F., et al. Larger corpus callosum size with better motor performance in prematurely born children. Semin Perinatol 28 (2004) 279-287
12. Kaufman A.S. Intelligent Testing With the WISC-R. 1979 (1979), Wiley, New York, NY
13. Rey A. L'examen clinique en psychologie (2005), Presses Universitaires de France, Paris
14. Beery K.E. The VMI Developmental Test of Visual Motor Integration: Administration, Scoring and Teaching Manual (1997), Modern Curriculum Press, Cleveland, Ohio
15. Hendersen S.E., and Sugden E.D. The Movement Assessment Battery for Children (1992), The Psychological Cooperation Ltd, London, UK
16. Kurth T., Walker A.M., Glynn R.J., Chan K.A., Gaziano J.M., Berger K., et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163 (2006) 262-270
17. Baden M., Bauer C.R., Colle E., Klein G., Taeusch Jr. H.W., and Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 50 (1972) 526-534
18. Taeusch Jr. H.W., Wang N.S., Baden N., Bauer C.R., and Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome, II: Pathology. Pediatrics 52 (1973) 850-854
19. Fitzhardinge P.M., Eisen A., Lejtenyi C., Metrakos K., and Ramsay M. Sequelae of early steroid administration to the newborn infant. Pediatrics 53 (1974) 877-883
20. Mammel M.C., Green T.P., Johnson D.E., and Thompson T.R. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1 (1983) 1356-1358
21. Avery G.B., Fletcher A.B., Kaplan M., and Brudno D.S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75 (1985) 106-111
22. Hack M., and Fanaroff A.A. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum Dev 53 (1999) 193-218
23. Thebaud B., Lacaze-Masmonteil T., and Watterberg K. Postnatal glucocorticoids in very preterm infants: 'the good, the bad, and the ugly'?. Pediatrics 107 (2001) 413-415
24. Andre P., Thebaud B., Odievre M.H., Razafimahefa H., Zupan V., Dehan M., et al. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease. Intensive Care Med 26 (2000) 1496-1500
25. Decastro M.H., and LaGamma E.F. Postnatal use of betamethasone (BETA) vs dexamethasone (DEX) for treatment of evolving BPD in extremely low birth weight (ELBW) neonates (abstract). Pediatr Res (2005) 2069A
26. Heide-Jalving M., Kamphuis P.J., van der Laan M.J., Bakker J.M., Wiegant V.M., Heijnen C.J., et al. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?. Acta Paediatr 92 (2003) 827-835
27. Watterberg K.L., Gerdes J.S., Gifford K.L., and Lin H.M. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 104 (1999) 1258-1263
28. Watterberg K.L., Gerdes J.S., Cole C.H., Aucott S.W., Thilo E.H., Mammel M.C., et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 114 (2004) 1649-1657
29. Watterberg K.L., Scott S.M., Backstrom C., Gifford K.L., and Cook K.L. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 105 (2000) 320-324
30. Reist M., Marshall K.A., Jenner P., and Halliwell B. Toxic effects of sulphite in combination with peroxynitrite on neuronal cells. J Neurochem 71 (1998) 2431-2438
31. Baud O., Laudenbach V., Evrard P., and Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res 50 (2001) 706-711
32. Finer N.N., Powers R.J., Ou C.H., Durand D., Wirtschafter D., and Gould J.B. Prospective evaluation of postnatal steroid administration: a 1-year experience from the California Perinatal Quality Care Collaborative. Pediatrics 117 (2006) 704-713
33. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev (2003) CD001144
34. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev (2003) CD001145
35. Grier D.G., and Halliday H.L. Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use. Drugs 65 (2005) 15-29